On September 19, 2022, AIM ImmunoTech Inc. filed a definitive proxy statement soliciting proxies and urged the shareholders to vote for the election of its nominees, Thomas K. Equels, William M. Mitchell, and Stewart L. Appelrouth, as directors of the Company at the Company's annual shareholders meeting scheduled to be held on November 3, 2022.